ucuz ucak bileti onurair turk hava yollari sun express anadolu jet atlas jet flypgs pegasus en ucuz ucak bileti pegasus
Welcome To Lactonova

global@lactonova.com +91-40-65949409 / 27171323

LACTOSORB COMPLEX

VIRTUAL CARE FOR YOUR PRECIOUS HEART

A patent pending all natural proprietary ingredient designed to reduce LDL (bad cholesterol),VLDL, Triglycerides, total cholesterol and marked increase in HDL(good cholesterol) levels with preclinical evidence for the first time in India.

LACTOSORB COMPLEX

  • Specially designed multilayered structured matrix granules with one to one action..
  • Stimulates lipid thermogenesis
  • Binds to dietary fat
  • Decreases food intake
  • Inhibits the digestion of carbohydrates

LACTOSORB’s unique triple action

DISTINCTIVE ACTION OF LACTOSORB COMPLEX

  • Lactosorb complex is a specially designed multilayered structured matrix granules which are dispersed in the gastric lumen almost immediately.
  • Lactosorb complex is only activated when it encounters fat.
  • Lactosorb complex can only be eliminated by natural transit after binding and reacting with fats.
  • Binding to the fats, lactosorb complex prevents lipase and amylase action by blocking the fatty acids and carbohydrates thus a large part of fats and carbohydrates from food are no longer absorbed but are eliminated through natural transit.
  • Lactosorb complex is attracted to lipids which are non-degraded(visible fats).
  • One of the special ingredients in Lactosorb complex effectively stimulates thermogenesis.

SUPPORTING PRECLINICAL EVIDENCE:

21days preclinical study with a supplementation of human equivalent dose (HED) of 160mg/day has shown the following results

  • TC level was gradually decreased by the 21st day of the study period when compared to other tested doses.

21DAYS PRE-CLINICAL STUDY RESULTED IN 27.4% REDUCTION IN TOTAL CHOLESTEROL

TG level was gradually decreased by the 21st day of the study period when compared to other tested doses.

21 DAYS PRE-CLINICAL STUDY RESULTED IN 31.79% REDUCTION IN TRIGLYCERIDES

LDL level was gradually decreased by the 21st day of the study period when compared to other tested doses.

21 DAYS PRE-CLINICAL STUDY RESULTED IN 58.79% REDUCTION OF LDL

VLDL level was gradually decreased by the 21st day of the study period when compared to other tested doses.

21 DAYS PRE-CLINICAL STUDY RESULTED IN 35.25% REDUCTION OF VLDL

HDL level was gradually increased by the 21st day of the study period when compared to other tested doses.

21 DAYS PRE-CLINICAL STUDY RESULTED IN 19.76% INCREASE IN HDL

Feed intake level was gradually decreased by the 21st day of the study period when compared to other tested doses.

21 DAYS PRE-CLINICAL STUDY RESULTED IN 26.4% DECREASE IN FEED INTAKE

Conclusion:

The lipids like TC, TG, LDL in excess and VLDL are considered to be bad fats and may lead to lot of health complications including, cardiovascular system, whereas HDL is considered to be good fat and has beneficial effects on the body. The PRE-CLINICAL EVIDENCE shows decrease in bad fat and increase in good fat levels, this tested extract has hypocholesterolemic activity with an additional benefit of weight reduction property.

Pre clinical study showed a reduction in:

  • 27.4% of total cholesterol
  • 31.79% of tri glycerides
  • 58.79 % of LDL
  • 35.25% OF VLDL
  • 26.4% of food intake

Increase in 19.76 % HDL

Featured Products

Actiferon
Read More

LACTOWHEY
Read More

MUCOGUARD
Read More

istanbul escort istanbul escort istanbul escort

Contact Info

Address:
Lactonova Nutripharm Pvt Ltd.
Plant: # 81-3, IDA Mallapur,
Uppal (M), Hyderabad-500076,
Telangana, INDIA.
Corp. Off: Habsiguda,
State : Telangana
Pincode : 500007
Country : INDIA